Chairman and The Grainger Professor, Department of Psychiatry, Rush University Medical Center
Psychiatry
Dr. Mark Pollack, DC
|
|
Give Review
Mark Pollack practices Psychiatry. He graduated from Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76/0 in Research/PrimaryCare. He received 2 awards: "America's Top Doctors" and "Chicago Magazine: Top Doctors". Mark Pollack is a published doctor. He published 99 publications, including: 'Enhancement of Psychosocial Treatment With d-Cycloserine: Models, Moderators, and Future Directions.'
Publications
- Enhancement of Psychosocial Treatment With d-Cycloserine: Models, Moderators, and Future Directions.
- Brain connectomics predict response to treatment in social anxiety disorder.
- Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD.
- D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
- De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments.
- The Human Ortholog of Acid-Sensing Ion Channel Gene ASIC1a Is Associated with Panic Disorder and Amygdala Structure and Function.
- D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: Prognostic and prescriptive variables.
- Influence of RGS2 on Sertraline Treatment for Social Anxiety Disorder.
- Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals.
- Smiles may go unseen in generalized social anxiety disorder: Evidence from binocular rivalry for reduced visual consciousness of positive facial expressions.
- CORTICO-LIMBIC RESPONSES TO MASKED AFFECTIVE FACES ACROSS PTSD, PANIC DISORDER, AND SPECIFIC PHOBIA.
- Loving-Kindness Meditation practice associated with longer telomeres in women.
- Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.
- Predictors of dropout from psychosocial treatment in opioid-dependent outpatients.
- D-Cycloserine Enhancement of Fear Extinction is Specific to Successful Exposure Sessions: Evidence from the Treatment of Height Phobia.
- Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD.
- Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, dou...
- Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder.
- Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
- Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery.
- Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response.
- Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.
- Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
- Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
- Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder.
- Refractory generalized anxiety disorder.
- A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
- Open-label support for duloxetine for the treatment of panic disorder.
- Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.
- Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
- Anxiety is associated with impulsivity in bipolar disorder.
- Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
- Oxytocin levels in social anxiety disorder.
- Novel treatment approaches for refractory anxiety disorders.
- A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder.
- Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy.
- Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition.
- Complicated grief: a case series using escitalopram.
- Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
- Levetiracetam as adjunctive therapy for refractory anxiety disorders.
- Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.
- Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001.
- Preventing recurrent depression: long-term treatment for major depressive disorder.
- The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
- Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm.
- Resilience: research evidence and conceptual considerations for posttraumatic stress disorder.
- A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
- Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions.
- Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders.
- Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder.
- The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance.
- Panic attacks, daily life ischemia, and chest pain in postmenopausal women.
- Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
- Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
- An open-label trial of risperidone augmentation for refractory anxiety disorders.
- Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
- Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
- Somatic-focused therapy for traumatized refugees: Treating posttraumatic stress disorder and comorbid neck-focused panic attacks among cambodian refugees.
- Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation.
- Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions.
- Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder.
- Using neuroimaging to predict treatment response in mood and anxiety disorders.
- Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis.
- Rates of isolated sleep paralysis in outpatients with anxiety disorders.
- A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design.
- Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.
- The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
- Complicated grief and its correlates in patients with bipolar disorder.
- Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
- Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study.
- Discussion: using benzodiazepines in clinical practice.
- Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
- Comorbid anxiety and depression.
- Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity.
- Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample.
- The pharmacotherapy of panic disorder.
- Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (S...
- CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study.
- An open-label study of levetiracetam for the treatment of social anxiety disorder.
- Unmet needs in the treatment of anxiety disorders.
- Long-term management of panic disorder.
- Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.
- Exploring the psychometric properties and construct validity of the MCMI-III anxiety and avoidant personality scales.
- Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder.
- Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
- Predicting panic disorder among patients with chest pain: an analysis of the literature.
- Establishment of remission criteria for anxiety disorders.
- Treatment of panic disorder: focus on paroxetine.
- Bupropion sustained release for panic disorder.
- A novel cognitive-behavioral approach for treatment-resistant drug dependence.
- Citalopram for social anxiety disorder: an open-label pilot study in refractory and nonrefractory patients.
- History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder.
- Quality of life in social anxiety disorder compared with panic disorder and the general population.
- Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.
- Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
- New advances in the management of anxiety disorders.
- Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.
- Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.
Doctors Specialties
- Chiropractic
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
Education
-
Massachusetts General Hospital -
Rutgers New Jersey Medical School
Hospital
-
Massachusetts General Hospital -
Rush University Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Simone Litsch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen D. Hutchins, DC
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darlene S. Lara, DC |